Ingersoll Rand Inc. (IR)

FairStock Score: 49/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a Buffett-and-Graham-minded investor, I start with the business and then ask what I am paying. Ingersoll Rand is a real industrial franchise: it sells mission-critical air, fluid, clean-energy and medical technologies, and its latest filed quarter—fiscal Q2 2026, the quarter ended 2026-06-30—showed revenue of $2.0B, net income of $256.8M, and a 12.53% margin. That is a sharp swing from fiscal Q2 2025, when net income was -$115.3M. Still, the longer record is uneven: FY2025 revenue was $7.7B versus $7.2B in FY2024, but net income fell to $581.4M from $838.6M, and diluted EPS fell to $1.45 from $2.06. FairStock calls it a Slow Grower because profit grew only 0.8% a year over four years while revenue grew 10.4%. Financial health is acceptable—D/E 0.48, Altman Z 2.71, Piotroski 7/9, and TTM FCF of $1.2B, a 4.2% FCF yield—but returns are modest: ROE 9.47% and ROCE 5.10%. At the 2026-10-26 close of $74.52, the FairStock P/E is 30.79, P/B 2.84, EV/EBITDA 16.06, and PEG 1.92. The Graham Number is $37.79, so the price sits about 94% above that conservative anchor. The moat case rests on mission-critical products and services, not on demonstrated high returns. I see a decent business, but not a clear margin of safety at this price.

In plain English: Ingersoll Rand makes and services industrial air, fluid, clean energy and medical equipment. The business looks reasonably strong because sales are growing and it produces free cash, but profits have been uneven and returns are modest. At the recent share price, the stock looks expensive compared with the company's earnings and the value shown in its financial statements.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-26 close · note generated 2026-10-28 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer